On May 24, 2024, local time in Turkey, KeyVac, a joint venture invested by Sinovac in Turkey, won the bid for Turkey's long-term supply project for hepatitis A and chickenpox vaccine.
科兴生物：KeyVac中标土耳其甲肝和水痘疫苗长期供应项目
Kexon Biotech: KeyVac won the bid for Turkey's long-term supply project for hepatitis A and chickenpox vaccines
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.